A team of physicists at the Institut Lumière Matière (CNRS/Université Claude Bernard Lyon 1), in collaboration with the Cancer Research Center of Lyon (CNRS/INSERM/ Université Claude Bernard Lyon 1/Centre Léon Bérard/Hospices civils de Lyon), has demonstrated the potential, for oncology, of an imaging technique based only on the physical properties of tumors. It can differentiate populations of malignant cells and monitor how effective an anticancer treatment is. These results, published in Physical Review Letters on January 8, 2019, should help in the design of new therapeutic molecules and in the personalization of treatments.
Despite a good understanding of the biology of cancer, 90% of experimental drugs fail during clinical trials. It is also increasingly suspected that the mechanical properties of tumors influence disease progression, and treatment efficacy. Although we can evaluate tumor elasticity globally, it is more difficult to measure local rigidity deep down and to see whether the core of the tumor resists the penetration of therapeutic liquids. To probe these physical properties, the researchers have used a noncontact imaging technique that does not require the use of contrast agents – therefore that does not disturb tissue function – that exploits natural infinitesimal vibrations of matter.
To recapitulate the behavior of colorectal tumors in vitro, the researchers created organoids, spheres with diameter 0.3 mm formed by the aggregation of tumor cells. They focused a red laser beam onto these objects. The infinitesimal vibrations of the sample, generated by thermal agitation, modify very slightly the color of the light beam that exits the sample. By analyzing this light, a map of the mechanical properties of the model tumors is created: the more rigid the area scanned by the laser, the faster the vibrations and, in a manner comparable to the Doppler effect (the mechanism that makes a siren sound increasingly shrill as it gets closer), the greater the color change.
From organoids composed of two cell lines with different malignancies, the researchers have shown that they could distinguish the two cell types from their mechanical properties. Such information is crucial because it may allow diagnosis from biopsy analysis to be refined and offer better assessment of tumor grade. Local variations in mechanical properties after a drug treatment have also been monitored using this technique: the center of the tumor remains rigid longer than the edge, demonstrating the treatment’s efficacy gradient. So local measurement of mechanical properties could confirm the total destruction of the tumor and help in choosing as low a treatment dose and duration as possible.
This approach allows exploring the impact of mechanical properties on the therapeutic response. It should lead to more predictive in vitro tumor models for testing new therapeutic molecules and for combined therapies, which act for example on tissue rigidity to accelerate the penetration of active molecules in the center of the tumor. It could also provide new indicators to guide clinicians in personalization of therapies.
Learn more: Physics can show us the inside of tumors
The Latest on: Personalized cancer treatment
via Google News
The Latest on: Personalized cancer treatment
- ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Testson January 10, 2020 at 5:08 am
ArcherDX also plans to seek regulatory approval and launch its Personalized Cancer Monitoring (PCM) product. The ArcherDX PCM platform would enable local labs to assess therapy success and identify ...
- EDITORIAL: Good news: More progress in the fight against canceron January 9, 2020 at 9:05 pm
In addition to human behavioral changes, credit medical science for much of the progress, particularly when it comes to detection and treatment ... “The $123 billion worldwide cancer drugs market is ...
- Natera Launches BESPOKE CRC Study to Evaluate Outcomes in 1,000 Signatera(TM) Patients with Stage II-III Colorectal Canceron January 9, 2020 at 4:46 pm
Signatera is a custom-built circulating tumor DNA (ctDNA) test for treatment monitoring and molecular residual disease (MRD) assessment in patients previously diagnosed with cancer. The test is ...
- BriaCell Outlines New High Responding Patient Group ‘Biomarker’ Based on Cancer Gradeon January 9, 2020 at 11:17 am
BriaCell has identified a patient population Biomarker with high rate of clinical benefit from the treatments based on ‘Breast Cancer Grade’;Breast Cancer Grade correlates with.
- Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025on January 9, 2020 at 5:05 am
/PRNewswire/ -- "Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025" Report Highlights: Read the full ...
- Ruth Bader Ginsburg says she is 'cancer-free' following radiation treatmenton January 8, 2020 at 4:36 pm
Ginsberg cancer treatment over the summer came just months after she had lung-cancer surgery ... Ginsburg called Trump a “faker” in a July 2016 CNN interview and faulted him for failing to disclose ...
- Advances in Lung Cancer Treatment Drops U.S. Cancer Deathson January 8, 2020 at 3:41 pm
/PRNewswire/ -- Today's report concerning improvements in cancer mortality is welcomed news. The recently released Cancer Statistics 2020 report shows that ...
- New Data Notes Financial Considerations for How Health Systems Support Childhood Cancer Survivorson January 8, 2020 at 6:25 am
MANHASSET, N.Y.--(BUSINESS WIRE)--Often known as “forgotten patients,” many childhood cancer survivors face long-term side effects and medical complications post-treatment. It is up to the health ...
- Global Cancer Tumor Organoids Research Insights, 2020-2025: Modeling, Technology & Personalized Canceron January 7, 2020 at 3:29 am
Dublin, Jan. 07, 2020 (GLOBE NEWSWIRE) -- The "Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025" report has been added to ResearchAndMarkets.com's ...
- Global Cancer Tumor Organoids Modeling, Clinical Research Insight 2025on January 6, 2020 at 3:56 am
Download Report: https://www.kuickresearch.com/report-global-cancer-tumor-organoids-modeling,-technology-and-personalized-cancer-research-insight-2025.php The development ... the confidence of working ...
via Bing News